HopeStage
Back to all studies
CompletedNCT00158262

Effect of Propranolol on Preventing PTSD

It focuses on PTSD and currently lists study information in the United States.

PTSDDrugFrom 18 Years to 55 Years
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 55 years.

Listed locations
Boston, United StatesSee all locations and recruitment

Compensation and expense reimbursement have not been verified for this summary.

Study clarity

Study information

Study start dateStarted: September 2004
Recruitment status
Completed
Enrollment listed in the registry
43
Sponsor
Massachusetts General Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT00158262
Official title
Prophylaxis of Posttraumatic Stress Disorder With Post-Trauma Propranolol

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Boston

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Propranolol and Placebo.

Who was this study for?

Listed age limits: 18 years to 55 years.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me